Avidity Biosciences Shares Community Letter Detailing Novartis Definitive Merger Acquisition

November 21, 2025

On November 20, 2025, Avidity Biosciences shared a Community Letter detailing their definitive merger acquisition by Novartis. This letter comes after the official announcement on October 26, 2025. 

To view Avidity’s Community Letter, please click here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open